跳至主要内容
临床试验/JPRN-jRCT1031190027
JPRN-jRCT1031190027已完成未知

A multicenter single-blind randomized study to compare effects of continuing and withholding angiotensin receptor blocker(ARB)-calcium blocker (CAB) combination tablets before surgery on perioperative hemodynamics in patients undergoing non-cardiac surgery - Effects of continuing vs withholding ARB/CAB combination tablets before surgery on perioperative hemodynamics

Hayashida Masakazu0 个研究点目标入组 110 人开始时间: 2019年5月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
110

研究概览

简要总结

Continuation of ARB/CCB combination tablets was effective in preventing hypertension before anesthesia. However, it increased a risk of hypotension during anesthesia and increased requirements of vasoconstrictor therapy. Further, it was not effective in preventing postoperative hypertension. Therefore, discontinuation of ARB/CCB combination tablets prior to general anesthesia seemed preferable to their continuation.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • Surgical patients with hypertension treated with ARB/CAB combination tablets

排除标准

  • Patients having severe comorbidities, including heart disease, and those scheduled for major surgery including cardiac surgery

研究者

发起方
Hayashida Masakazu

相似试验